Red Cell Distribution Width (RDW) as a Prognostic Marker in ICU

The aim of this study is to verify if high values of RDW are useful prognostic marker for ICU mortality and 90-days mortality. Moreover, we will investigate the prognostic value of RDW in specific subgroup population with some clinical characteristic wich may modify RDW baseline values, i.e. transfused patients or patients with high markers of hemolysis

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Blood Transfusion Biochemical Marker

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Sant'Anna Hospital

Ferrara, 44121, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Unselected ICU patients

Exclusion criteria

Length of stay in ICU <48 hours
Hematological disease
Age <18 years

Treatment and study plan

Primary outcomes

90-days mortality

Time frame: 90 days

Secondary outcomes

ICU mortality

Time frame: 90 days
Length of mechanical ventilation

Time frame: 90 days

Sponsors and collaborators

Lead sponsor

Università degli Studi di Ferrara

Other

Registry information

Important dates

Study start: 2016
Primary completion: 2016
Study completion: 2016
First posted: Sep 28, 2016
Registry last updated: Mar 30, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed